Savara Inc. (SVRA) is a publicly traded Healthcare sector company. As of May 21, 2026, SVRA trades at $4.95 with a market cap of $1.01B and a P/E ratio of -9.48. SVRA moved +7.84% today. Year to date, SVRA is -12.41%; over the trailing twelve months it is +62.04%. Its 52-week range spans $1.89 to $7.01. Analyst consensus is strong buy with an average price target of $11.00. Rallies surfaces SVRA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies organizes SVRA SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
| Metric | Value |
|---|---|
| Price | $4.95 |
| Market Cap | $1.01B |
| P/E Ratio | -9.48 |
| EPS | $-0.53 |
| Dividend Yield | 0.00% |
| 52-Week High | $7.01 |
| 52-Week Low | $1.89 |
| Volume | 476 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-118.84M |
| Gross Margin | 0.00% |
6 analysts cover SVRA: 0 strong buy, 6 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $11.00.